Keros Therapeutics, Inc.KROSNASDAQ
Loading
Debt to Assets Over TimeFair Value
Percentile Rank86
3Y CAGR+4.9%
5Y CAGR+71.8%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
+4.9%/yr
vs +10.7%/yr prior
5Y CAGR
+71.8%/yr
Recent deceleration
Acceleration
-5.8pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
15x
Strong expansion
Streak
1 yr
Consecutive growthFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.05 | +63.1% |
| 2024 | 0.03 | -21.5% |
| 2023 | 0.04 | -9.7% |
| 2022 | 0.04 | +909.9% |
| 2021 | 0.00 | +28.3% |
| 2020 | 0.00 | -97.1% |
| 2019 | 0.12 | +304.9% |
| 2018 | 0.03 | - |